⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL744648 | 1.00 | — | — | |
| SCHEMBL19285086 | 1.00 | — | — | |
| SCHEMBL260159 | 1.00 | — | — | |
| SCHEMBL19616035 | 1.00 | — | — | |
| SCHEMBL130804 | 0.84 | TDP1 (0.50) | — | |
| SCHEMBL129425 | 0.84 | TDP1 (0.50) | — | |
| SCHEMBL33424 | 0.84 | TDP1 (0.50) | — | |
| SCHEMBL924500 | 0.84 | — | — | |
| SCHEMBL4141863 | 0.84 | — | — | |
| SCHEMBL130805 | 0.84 | TDP1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12091425-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2024-09-17 | — | — | US | disclosed |
| US-12024529-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2024-07-02 | — | — | US | disclosed |
| US-12024529-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-115551862-B | Macrocyclic inhibitors of peptidyl arginine deiminase | 吉利德科学公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20230271981-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230271981-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2023-08-31 | — | — | US | disclosed |
| US-11685747-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685747-B2 | Compounds that inhibit MCL-1 protein | AMGEN INC. (US) | 2023-06-27 | — | — | US | disclosed |
| EP-3601297-B9 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC (US) | 2023-05-24 | — | — | EP | disclosed |
| CN-110691784-B | Compounds for inhibiting MCL-1 protein | 美国安进公司 | 2023-03-31 | — | — | CN | disclosed |
| EP-1506955-B1 | Bicyclic amino acids as pharmaceuticals agents | WARNER LAMBERT CO (US) | 2007-03-28 | — | — | EP | disclosed |
| US-7189747-B2 | Method of treating noninflammatory cartilage damage | WARNER-LAMBERT COMPANY (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189747-B2 | Method of treating noninflammatory cartilage damage | WARNER-LAMBERT COMPANY (US) | 2007-03-13 | — | — | US | disclosed |
| WO-2003063845-A1 | ALPHA 2 DELTA LIGANDS TO TREAT TINNITUS | WARNER-LAMBERT COMPANY LLC (US) | 2003-08-07 | — | — | WO | disclosed |
| US-4206127-A | ANTICOAGULANTS, ANTISECRETORY AGENTS | MILES LABORATORIES, INC. (US) | 1980-06-03 | — | — | US | disclosed |
| US-4149017-A | FERTILITY CONTROL, ANTIULCER AGENTS, BRONCHODILATOR, ANTICOAGULANT | MILES LABORATORIES, INC. (US) | 1979-04-10 | — | — | US | disclosed |
| US-4115438-A | SMOOTH MUSCLE ACTIVITY, ANTICLOTTING, ANTISECRETORY, BLOOD PRESSURE | MILES LABORATORIES, INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4115453-A | SMOOTH MUSCLE ACTIVITY, ANTICOAGULANTS, ANTISECRETORY, HYPOTENSIVE | MILES LABORATORIES, INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4108892-A | ANTICOAGULATNS, SMOOTH MUSCLE ACTIVITY MODIFIERS, ANTISECRETORY | MILES LABORATORIES, INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4074063-A | ANTISECRETORY AGENTS, ANTICOAGULANTS, HYPOTENSIVE AGENTS | MILES LABORATORIES, INC. (US) | 1978-02-14 | — | — | US | disclosed |